82 related articles for article (PubMed ID: 10938969)
21. Transfusion-associated graft-versus-host disease.
Dwyre DM; Holland PV
Vox Sang; 2008 Aug; 95(2):85-93. PubMed ID: 18544121
[TBL] [Abstract][Full Text] [Related]
22. Two cases of cutaneous chronic graft versus host disease in treatment with psoralen plus ultraviolet-A-bath photochemotherapy.
Hoffner MV; Carrizosa Esquivel A; Pulpillo Ruiz A; Herrera Saval A; Conejo-Mir J; Camacho FM
J Drugs Dermatol; 2009 Nov; 8(11):1027-9. PubMed ID: 19894371
[TBL] [Abstract][Full Text] [Related]
23. Graft versus host disease after liver transplantation - a single center experience and review of literature.
Kohler S; Pascher A; Junge G; Sauer IM; Nagy M; Schönemann C; Koch M; Neumann U; Pratschke J; Neuhaus P
Transpl Int; 2008 May; 21(5):441-51. PubMed ID: 18266778
[TBL] [Abstract][Full Text] [Related]
24. Acute graft-versus-host disease after liver transplant: novel use of etanercept and the role of tumor necrosis factor alpha inhibitors.
Thin L; Macquillan G; Adams L; Garas G; Seow C; Cannell P; Augustson B; Mitchell A; Delriveire L; Jeffrey G
Liver Transpl; 2009 Apr; 15(4):421-6. PubMed ID: 19326415
[TBL] [Abstract][Full Text] [Related]
25. [Influence of graft-versus-host disease on long-term survival of 26 patients with hematologic malignancies after transplantation].
Lin Q; Dong M; Wang QM; Wen JY; Wu XY
Ai Zheng; 2006 Oct; 25(10):1261-5. PubMed ID: 17059772
[TBL] [Abstract][Full Text] [Related]
26. Monitoring systemic donor lymphocyte macrochimerism to aid the diagnosis of graft-versus-host disease after liver transplantation.
Taylor AL; Gibbs P; Sudhindran S; Key T; Goodman RS; Morgan CH; Watson CJ; Delriviere L; Alexander GJ; Jamieson NV; Bradley JA; Taylor CJ
Transplantation; 2004 Feb; 77(3):441-6. PubMed ID: 14966423
[TBL] [Abstract][Full Text] [Related]
27. Post-transfusion graft-versus-host disease in immunocompetent patients after cardiac surgery in Japan.
Juji T; Takahashi K; Shibata Y; Ide H; Sakakibara T; Ino T; Mori S
N Engl J Med; 1989 Jul; 321(1):56. PubMed ID: 2733750
[No Abstract] [Full Text] [Related]
28. [Liver biopsy in the management of liver dysfunction after allogeneic hematopoietic stem-cell transplantation].
Chen H; Huang XJ; Liu KY; Xu LP; Wang H; Liu DH; Lu J; Lu DP
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3062-6. PubMed ID: 16324408
[TBL] [Abstract][Full Text] [Related]
29. Treatment of severe steroid refractory acute graft-versus-host disease with infliximab, a chimeric human/mouse antiTNFalpha antibody.
Kobbe G; Schneider P; Rohr U; Fenk R; Neumann F; Aivado M; Dietze L; Kronenwett R; Hünerlitürkoglu A; Haas R
Bone Marrow Transplant; 2001 Jul; 28(1):47-9. PubMed ID: 11498743
[TBL] [Abstract][Full Text] [Related]
30. Extracorporeal photopheresis for acute and chronic graft-versus-host disease: does it work?
Couriel D; Hosing C; Saliba R; Shpall EJ; Andelini P; Popat U; Donato M; Champlin R
Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):37-40. PubMed ID: 16399600
[TBL] [Abstract][Full Text] [Related]
31. [Treatment of transfusion-associated graft-versus-host disease].
Yasukawa M
Nihon Rinsho; 1997 Sep; 55(9):2290-5. PubMed ID: 9301292
[TBL] [Abstract][Full Text] [Related]
32. Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation.
Cutler C; Kim HT; Hochberg E; Ho V; Alyea E; Lee SJ; Fisher DC; Miklos D; Levin J; Sonis S; Soiffer RJ; Antin JH
Biol Blood Marrow Transplant; 2004 May; 10(5):328-36. PubMed ID: 15111932
[TBL] [Abstract][Full Text] [Related]
33. Allogeneic transplantation after reduced conditioning in high risk patients is complicated by a high incidence of acute and chronic graft-versus-host disease.
Schetelig J; Kröger N; Held TK; Thiede C; Krusch A; Zabelina T; Dubiel M; Rick O; Bornhäuser M; Ehninger G; Zander AR; Siegert W
Haematologica; 2002 Mar; 87(3):299-305. PubMed ID: 11869943
[TBL] [Abstract][Full Text] [Related]
34. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
35. Characterization of acute graft-versus-host disease following reduced-intensity stem-cell transplantation from an HLA-identical related donor.
Murashige N; Kami M; Mori S; Katayama Y; Kobayashi K; Onishi Y; Hori A; Kishi Y; Hamaki T; Tajima K; Kanda Y; Tanosaki R; Takaue Y
Am J Hematol; 2008 Aug; 83(8):630-4. PubMed ID: 18454459
[TBL] [Abstract][Full Text] [Related]
36. [Methotrexate for treatment of graft versus host disease after allogeneic hematopoietic stem cell transplantation].
Huang XJ; Jiang Q; Chen H; Xu LP; Liu DH; Chen YH; Han W; Zhang YC; Liu KY; Lu DP
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(16):1097-101. PubMed ID: 16029565
[TBL] [Abstract][Full Text] [Related]
37. Serine protease inhibitor nafamostat given before reperfusion reduces inflammatory myocardial injury by complement and neutrophil inhibition.
Schwertz H; Carter JM; Russ M; Schubert S; Schlitt A; Buerke U; Schmidt M; Hillen H; Werdan K; Buerke M
J Cardiovasc Pharmacol; 2008 Aug; 52(2):151-60. PubMed ID: 18670364
[TBL] [Abstract][Full Text] [Related]
38. Potential usefulness of photochemotherapy using 8-methoxypsoralen in the treatment of posttransfusion graft-versus-host disease.
Nishimura M; Akaza T; Tadokoro K; Juji T
Vox Sang; 1998; 75(4):306-7. PubMed ID: 9873267
[No Abstract] [Full Text] [Related]
39. [Possible involvement of donor-derived B cells in development of post-transfusion graft-versus-host disease].
Nishimura M; Akaza T; Tadokoro K; Juji T
Nihon Rinsho; 1997 Sep; 55(9):2246-51. PubMed ID: 9301284
[TBL] [Abstract][Full Text] [Related]
40. Pre-emptive immunotherapy with CD8-depleted donor lymphocytes after CD34-selected allogeneic peripheral blood stem cell transplantation.
Baron F; Siquet J; Schaaf-Lafontaine N; Baudoux E; Hermanne JP; Fillet G; Beguin Y
Haematologica; 2002 Jan; 87(1):78-88. PubMed ID: 11801468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
